Navigation Links
Promising therapy for relapsing multibple sclerosis
Date:2/16/2010

MS, that are characterized by abnormal T-cell responses.

Rose and his colleagues performed a randomized, double-blind, placebo-controlled study at 51 centers in the U.S., Canada, Germany, Italy, and Spain. They recruited 230 patients with relapsing MS who were taking interferon beta and randomly assigned them to receive add-on treatment with high-dose daclizumab, low-dose daclizumab, or placebo. The primary objective of the study was to assess whether daclizumab affected MS disease activity by measuring the total number of new or enlarged lesions in the brain during 24 weeks of treatment.

In addition to finding that add-on treatment with high-dose daclizumab resulted in a significantly lower number of new or enlarged MS lesions, the researchers found that patients treated with either high- or low-dose daclizumab had a seven to eight times higher number of immune cells called CD56bright natural killer cells (NK Cells). Previous research has shown that untreated MS patients have lower numbers of these NK cells than healthy individuals.

"Several lines of evidence point to a potential function for CD56bright natural killer cells in regulating the immune system," explains Rose. "This study provides confirmatory data that daclizumab treatment causes an expansion of CD56bright natural killer cells and adds support to the theory that this expansion might mediate some of the effects of daclizumab on reducing multiple sclerosis lesion activity." Further research is needed to clarify whether the risk-benefit of daclizumab is better when the drug is used alone or in combination with interferon beta, as well as to determine the optimum dose and length of treatment needed to see the full therapeutic effects of the drug.

"The CHOICE trial showed that treatment with daclizumab was associated with both a significant reduction in MS lesion formation and a robust increase in important cells that help to regulate the immune system," concludes Ro
'/>"/>

Contact: Dennis Jolley
dennis.jolley@hsc.utah.edu
801-581-5777
University of Utah Health Sciences
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. First blinded study of venous insufficiency prevalence in MS shows promising results
2. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
3. Promising new neuroimaging techniques for early detection of Alzheimers disease
4. LSUHSC research yields promising stroke treatment
5. Promising New Results On The Added Safety Of Using SmokeStik Electronic Cigarettes In The Bid To Quit Smoking
6. UV LED therapy shows promising results in preventing focal seizures
7. New insights into mushroom-derived drug promising for cancer treatment
8. Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability
9. Promising pharmaceutical agents emerge as sports doping products
10. Pneumonia Drug Promising Against Form of Muscular Dystrophy
11. Health Alliance Announces Promising Nine-Month Results from First Ever Outcome-Based Reimbursement Program for Actonel(R) (risedronate sodium) Tablets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... June 02, 2015 Atlantic Spine ... spine surgery with three locations in New Jersey, announces ... City. The new facility is at 1045 Park Avenue ... consultations and appointments can be arranged by calling 1-844-912-2406. ... at Atlantic Spine Center, has been a pioneer in ...
(Date:6/2/2015)... SB 277 (CA Legislature, bit.ly/1Q0P8OY) will require ... public or private school. SB277 cleared three Senate policy ... Committee (Sacramento Bee, May 11, 2015, bit.ly/1Gh9jU7). It passed ... “We believe that this bill affects the education of ... will (the) affect public health of California.. It is ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 Specialty ... audit, compliance and risk solutions , and Radar ... risk management effectiveness gap-improvement program. , All organizations ... uncertainty on objectives. Organizations not only assess and ... capabilities to do this (risk managing) thereby embedding ...
(Date:6/1/2015)... Garden City, NY (PRWEB) June 02, 2015 ... honors Miriam Wirski as a 2015-2016 ... She is recognized with this prestigious distinction for leadership ... exclusively for professional women, boasting more than 700,000 members ... to present Miriam with this prestigious honor,” said NAPW ...
(Date:6/1/2015)... City, NY (PRWEB) June 02, 2015 ... honors Marcy Herrmann as a 2015-2016 inductee ... is recognized with this prestigious distinction for leadership in ... exclusively for professional women, boasting more than 700,000 members ... honor to present Marcy with this distinction,” said NAPW ...
Breaking Medicine News(10 mins):Health News:Renowned Endoscopic Spine Surgeon Dr. Kaixuan Liu Announces Opening of Park Avenue Office 2Health News:A Voice For Choice Releases A Statement As SB277 Is Referred To Single Assembly Committee And Bypasses Education and Judicial Scrutiny 2Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 2Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 3Health News:Specialty Technical Publishers and Radar Launch Online Assessment Program for Evaluation of Risk Management Effectiveness 4Health News:National Association of Professional Women Inducts Miriam Wirski, Holistic Life Coach, Into its VIP Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Marcy Herrmann, Therapist, Life Coach, Advanced Handwriting Analyst, Into its VIP Professional Woman of the Year Circle 2
... twins were conjoined from the breast bone to the ... pediatricians and nurses at Children,s Hospital of Pittsburgh of ... procedure.The 2-year-old twin girls -- Dagian and Danielle Lee, ... began at 6:30 a.m. Saturday, Dec. 13, 2008, and ...
... lead to more headaches, new study suggests , , MONDAY, Feb. ... by taking naps to sleep it off, but they run ... patterns and perpetuating the cycle of headaches, a new study ... things people tried to treat their headaches, and they rated ...
... a statement by American Heart Association President Timothy Gardner, ... provisions in the economic stimulus package are a win-win ... with increased financial burdens. Americans suffering from chronic ... -- see a doctor or pay for food and ...
... One of the nation,s first group of fertility ... cost reduction to patients challenged by economic downturnSAN ... a 25th-anniversary celebration, one of the nation,s first ... to couples and individuals struggling to find ways ...
... ARLINGTON, Texas, Feb. 16 Across the nation, countless ... executives at one North Texas healthcare company took some ... from being another victim to the economic crisis.2009 looks ... now in its 7th year. One year ago ten ...
... AlphaVax announced today that it has ... Regulatory, Quality and Clinical Operations. In this capacity ... the areas of regulatory and quality affairs and ... trials, developing regulatory strategy and gaining regulatory approval ...
Cached Medicine News:Health News:Conjoined Twins Separated by Surgical Team at Children's Hospital of Pittsburgh of UPMC During Complex, 24-Hour Procedure 2Health News:Using Sleep to Manage Headaches May Cause Insomnia 2Health News:Using Sleep to Manage Headaches May Cause Insomnia 3Health News:Statement by American Heart Association President Timothy Gardner, M.D. on Congressional Approval of Economic Stimulus Package 2Health News:Bay Area Fertility Clinic to Offer Special Help During Recession 2Health News:Staying Healthy in 2009 2Health News:AlphaVax Announces New Vice President of Regulatory, Quality and Clinical Operations 2
(Date:6/1/2015)... Novel t reatments   entering the ... GBI Research . ... driven primarily by the introduction of numerous premium therapies, particularly ... or combine with generic chemotherapies. Analysis from business ... Market to 2020 - forecasts the value of the ...
(Date:6/1/2015)... NEW YORK , June 1, 2015 ... FDA-approved transcutaneous electrical nerve stimulation device specifically authorized for ... released significant data from a new PET trial showing ... the areas in the brain in migraine patients, namely ... Positron Emission Tomography (PET) scan, which is an imaging test of ...
(Date:6/1/2015)... , May 29, 2015 Research ... addition of the "Global A Dialyzer Reprocessing ... report to their offering. The ... ) Industry Report 2014 is a professional and ... A dialyzer reprocessing machine industry. The report ...
Breaking Medicine Technology:New Therapies to Enhance Increasingly Competitive Non-Small Cell Lung Cancer Treatment Market 2New Therapies to Enhance Increasingly Competitive Non-Small Cell Lung Cancer Treatment Market 3New Study Shows CEFALY Returns Normal Metabolic Activity to Brain Areas in Migraine Patients 2Global A Dialyzer Reprocessing Machine (A Dialyzer Reprocessor) Industry Report 2014 - Development Trends Forecasts to 2020 2Global A Dialyzer Reprocessing Machine (A Dialyzer Reprocessor) Industry Report 2014 - Development Trends Forecasts to 2020 3
... Loss, Lower Blood Sugar and Improved A1CHORSHAM, Pa., April 21 ... loss program that delivers to your door, today announced the ... specifically for the approximately 24 million Americans with diabetes, as ... for diabetes. In a clinical study at Temple ...
... clinical trial strategies for personalized approach to cancer ... a wholly-owned subsidiary of Cell Therapeutics, Inc. (CTI) ... preclinical study, which utilized RNA interference (RNAi) and ... vulnerability" - that enhance the anti-tumor response to ...
Cached Medicine Technology:New Weight Loss Hope for People with Diabetes 2New Weight Loss Hope for People with Diabetes 3New Weight Loss Hope for People with Diabetes 4New Weight Loss Hope for People with Diabetes 5New Weight Loss Hope for People with Diabetes 6Genes Identified That Enhance Tumor Cell Sensitivity to CTI's Cancer Drug Brostallicin 2Genes Identified That Enhance Tumor Cell Sensitivity to CTI's Cancer Drug Brostallicin 3Genes Identified That Enhance Tumor Cell Sensitivity to CTI's Cancer Drug Brostallicin 4
Refrigerator specially designed for the storage of blood in standard 500ml bags, complying with Australian Standard AS3864 1997....
TBR-120-1-GD is large capacity upright style refrigerator with an operating temperature of +4C. It is a specially designed refrigerator for the storage of blood in standard 500ml bags, complying with...
TBR-720-2-GD is large capacity upright style operating temperature +4C. It is specially designed refrigerators for the storage of blood in standard 500ml bags, complying with Australian Standard AS38...
... is a direct competitive EIA for ... human serum or plasma. A specific ... making it available for antibody binding. ... antibody linked to fluorescein isothiocyanate (FITC) ...
Medicine Products: